Commonwealth Bank of Australia’s Gilead Sciences GILD Stock Holding History

Commonwealth Bank of Australia’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-236,032	Closed	-$15.9M	–	395
2019 Q2	$15.9M	Sell	236,032 -102,092	-30%	-$6.72M	0.15%	96
2019 Q1	$22M	Buy	338,124 +78,797	+30%	+$5.24M	0.21%	75
2018 Q4	$16.2M	Sell	259,327 -2,958	-1%	-$207K	0.18%	84
2018 Q3	$20.2M	Sell	262,285 -5,262	-2%	-$397K	0.2%	88
2018 Q2	$18.9M	Buy	267,547 +7,572	+3%	+$535K	0.19%	83
2018 Q1	$19.6M	Sell	259,975 -45,034	-15%	-$3.58M	0.21%	82
2017 Q4	$21.8M	Buy	305,009 +20,979	+7%	+$1.59M	0.21%	89
2017 Q3	$23M	Buy	284,030 +30,482	+12%	+$2.33M	0.22%	88
2017 Q2	$17.9M	Buy	253,548 +40,150	+19%	+$2.67M	0.18%	98
2017 Q1	$14.5M	Buy	213,398 +50,661	+31%	+$3.56M	0.16%	104
2016 Q4	$11.7M	Buy	162,737 +37,260	+30%	+$2.77M	0.14%	113
2016 Q3	$9.93M	Buy	125,477 +22,300	+22%	+$1.81M	0.12%	120
2016 Q2	$8.61M	Buy	103,177 +5,591	+6%	+$496K	0.1%	129
2016 Q1	$8.96M	Buy	97,586 +35,440	+57%	+$3.2M	0.11%	123
2015 Q4	$6.29M	Buy	62,146 +24,347	+64%	+$2.53M	0.08%	155
2015 Q3	$3.71M	Buy	37,799 +66	+0.2%	+$7.33K	0.05%	212
2015 Q2	$4.42M	Sell	37,733 -3,092	-8%	-$338K	0.06%	174
2015 Q1	$4.01M	Sell	40,825 -2,000	-5%	-$203K	0.05%	184
2014 Q4	$4.04M	Sell	42,825 -29,537	-41%	-$3.05M	0.06%	174
2014 Q3	$7.7M	Sell	72,362 -2,200	-3%	-$215K	0.1%	137
2014 Q2	$6.18M	Sell	74,562 -762,295	-91%	-$59.3M	0.08%	152
2014 Q1	$59.3M	Buy	836,857 +68,701	+9%	+$5.39M	0.38%	68
2013 Q4	$57.7M	Buy	768,156 +94,488	+14%	+$6.58M	0.4%	55
2013 Q3	$42.4M	Sell	673,668 -158,600	-19%	-$9.48M	0.31%	79
2013 Q2	$42.7M	Buy	+832,268	New	+$43.4M	0.32%	79

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Commonwealth Bank of Australia's GILD Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 236,032 shares — an estimated $15.9M sold.

Commonwealth Bank of Australia first reported a position in GILD in Q2 2013 and held it in 25 quarters. The position peaked at $59.3M in Q1 2014. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

Commonwealth Bank of Australia reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 236,032 Gilead Sciences shares in Q3 2019, an estimated $15.9M.
Commonwealth Bank of Australia first reported a position in Gilead Sciences in Q2 2013 and held it in 25 quarters.
Commonwealth Bank of Australia's Gilead Sciences position peaked at $59.3M in Q1 2014.
1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.